Furthermore, low expression levels of microRNA-124-5p can lead to a poor prognosis of CRC via targeting of SMC4, which further confirms the novel tumor prognostic marker and potential tumor therapeutic target role of SMC4 in CRC (32). Here, SMC4 is linked to colorectal carcinoma.